Drug Profile
DRF-NPPC
Latest Information Update: 26 Jul 2010
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 08 Aug 2003 Suspended - Preclinical for Type-2 diabetes mellitus in India (unspecified route)
- 18 Dec 2000 DRF-NPPC is available for licensing (www.drreddys.com)
- 18 Dec 2000 Preclinical development for Type-2 diabetes mellitus in India (Unknown route)